TipRanks
Quantum Biopharma (DE:0K91)
FRANKFURT:0K91
Germany Market
0K91
Quantum Biopharma
RESEARCH TOOLSreports

Quantum Biopharma (0K91) Income Statement

0 Followers

Quantum Biopharma Income Statement

Last quarter (Q2 2026), Quantum Biopharma's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, Quantum Biopharma's net income was C$-3.17M. See Quantum Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 15.30M$ 16.14M$ 23.79M$ 27.43M$ 33.74M
Depreciation and Amortization
$ 545.78K$ 490.57K$ 2.51M$ 4.54M$ 4.05M
EBITDA
$ -25.79M$ -14.38M$ -15.72M$ -22.12M$ -29.82M
Operating Income
$ -15.30M$ -16.14M$ -23.79M$ -27.43M$ -33.74M
Other Income/Expenses
$ -11.65M$ 1.22M$ 5.56M$ 725.95K$ -194.30K
Pretax Income
$ -26.96M$ -14.92M$ -18.23M$ -26.70M$ -33.94M
Net Income
$ -26.18M$ -14.20M$ -17.90M$ -23.61M$ -35.29M
Per Share Metrics
Basic EPS
$ -8.11$ -12.49$ -29.39$ -39.62$ -65.63
Diluted EPS
$ -8.11$ -12.49$ -29.39$ -39.62$ -65.63
Weighted Average Shares Outstanding
 3.29M 1.14M 609.06K 595.88K 537.62K
Weighted Average Shares Outstanding (Diluted)
 3.29M 1.14M 609.06K 595.88K 537.62K

Quantum Biopharma Earnings and Revenue History